Cognizant: stable revenue in Q3

Cognizant (Nasdaq: CTSH), one of the world's leading professional services companies, today announced its third quarter 2020 financial results.

Coginzant infographic highlights 2020

Cognizant results
,
  • Revenue of $4.2 billion, down 0.1% (0.7% in constant currency1) including a negative 130 basis points impact from the exit of certain content services
  • GAAP operating margin was 14.2% vs. 15.7% in the prior year period while GAAP diluted EPS was $0.64, including a negative one-time tax impact2 of $0.26 per share, vs. $0.90 in the prior year period
  • Adjusted Operating Margin1 was 15.9% vs.17.3% in the prior year period while Adjusted Diluted EPS1 was $0.97 vs. $1.08 in the prior year period
  • Year-to-date bookings1 increased 15%
  • Year-to-date cash flow from operations of $2.4 billion and free cash flow1 of $2.1 billion
  • Since the beginning of Q3 through October 27th, returned to shareholders over $700 million through share repurchases and $120 million in dividends
  • FY2020 revenue expected to be at the high end of the previously guided range at approximately $16.7 billion, or a decline of 0.4% in constant currency. Adjusted Diluted EPS3 in the range of $3.63 - $3.67, an increase from prior guidance of $3.48-3.58

    "Against a challenging demand environment, we continued to strengthen our portfolio, execute our digital strategy and increase our competitiveness," said Brian Humphries, Chief Executive Officer. "Clients are realizing they can distinguish themselves if they embrace disruption and transform. We are committed to making that easy for them."

    Third Quarter 2020 Performance by Business Segment

    Financial Services (34.6% of revenues) revenue decreased 1.5% year-over-year, or 2.2% in constant currency, driven by declines in both banking and insurance. Growth in regional banks and capital markets in North America was offset by weakness in select global banking accounts and in Europe.

    Healthcare (29.0% of revenues) revenue grew 4.8% year-over-year, or 4.2% in constant currency, driven by life sciences. Growth in bio pharmaceutical clients and revenue from our acquisition of Zenith Technologies offset weakness in medical device clients. Within healthcare, performance among payer clients improved.

    Products and Resources (21.9% of revenues) revenue decreased 4.0% year-over-year, or 4.6% in constant currency. The decline was driven by retail, consumer goods, travel and hospitality clients that were particularly adversely affected by the pandemic, partially offset by double-digit constant currency growth in manufacturing, logistics, energy and utilities.

    Communications, Media and Technology (14.5% of revenues) revenue increased 0.2% year-over-year, or a decline of 0.2% in constant currency. Growth within our communications and media clients was more than offset by a negative 920 basis point impact from our 2019 strategic decision to exit certain content-related services. Excluding that impact, Communications, Media and Technology grew approximately 9% in constant currency.

    "Our cost discipline and strong year-to-date cash flow enabled continued investments in growth initiatives. We took further actions to increase our financial flexibility in support of our strategic priorities," said Jan Siegmund, Chief Financial Officer. "Since the beginning of the third quarter, we returned over $800 million of capital to shareholders through share repurchases and dividends."

    Full Year 2020 Outlook

    The Company is providing the following guidance:

  • Full year 2020 revenue expected to be approximately $16.7 billion, or a decline on a constant currency basis of 0.4%. This assumes an estimated negative 10 basis points foreign exchange impact and a negative 110 basis points impact from the exit of certain content services
  • Full year 2020 Adjusted Operating Margin4 expected to be approximately 15%
  • Full year 2020 Adjusted Diluted EPS expected to be in the range of $3.63-3.67